
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Tubular injury in diabetic kidney disease: molecular mechanisms and potential therapeutic perspectives
Yu Wang, Mingyue Jin, Chak Kwong Cheng, et al.
Frontiers in Endocrinology (2023) Vol. 14
Open Access | Times Cited: 41
Yu Wang, Mingyue Jin, Chak Kwong Cheng, et al.
Frontiers in Endocrinology (2023) Vol. 14
Open Access | Times Cited: 41
Showing 1-25 of 41 citing articles:
Endothelial dysfunction in vascular complications of diabetes: a comprehensive review of mechanisms and implications
Dongrong Yang, Meng‐Yan Wang, Chenglin Zhang, et al.
Frontiers in Endocrinology (2024) Vol. 15
Open Access | Times Cited: 37
Dongrong Yang, Meng‐Yan Wang, Chenglin Zhang, et al.
Frontiers in Endocrinology (2024) Vol. 15
Open Access | Times Cited: 37
Molecular Targets of Novel Therapeutics for Diabetic Kidney Disease: A New Era of Nephroprotection
Alessio Mazzieri, Francesca Porcellati, Francesca Timio, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 7, pp. 3969-3969
Open Access | Times Cited: 14
Alessio Mazzieri, Francesca Porcellati, Francesca Timio, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 7, pp. 3969-3969
Open Access | Times Cited: 14
Dysfunctional glucose metabolism triggers oxidative stress to induce kidney injury in diabetes
Meng Gao, Meng-Ting Dai, Guohua Gong
World Journal of Diabetes (2025) Vol. 16, Iss. 4
Closed Access | Times Cited: 1
Meng Gao, Meng-Ting Dai, Guohua Gong
World Journal of Diabetes (2025) Vol. 16, Iss. 4
Closed Access | Times Cited: 1
Integrated Network Pharmacology Analysis and Experimental Validation to Elucidate the Mechanism of Acteoside in Treating Diabetic Kidney Disease
Shu Jiao Zhang, Yi Fei Zhang, Xue Bai, et al.
Drug Design Development and Therapy (2024) Vol. Volume 18, pp. 1439-1457
Open Access | Times Cited: 4
Shu Jiao Zhang, Yi Fei Zhang, Xue Bai, et al.
Drug Design Development and Therapy (2024) Vol. Volume 18, pp. 1439-1457
Open Access | Times Cited: 4
Canagliflozin Inhibits Hedgehog Interacting Protein (Hhip) Induction of Tubulopathy in Diabetic Akita Mice
Shiao‐Ying Chang, Min-Chun Liao, Kana N. Miyata, et al.
Translational research (2025) Vol. 277, pp. 13-26
Closed Access
Shiao‐Ying Chang, Min-Chun Liao, Kana N. Miyata, et al.
Translational research (2025) Vol. 277, pp. 13-26
Closed Access
Mitochondria-dependent apoptosis was involved in the alleviation of Jujuboside A on diabetic kidney disease-associated renal tubular injury via YY1/PGC-1α signaling
Tingting Yang, Yuting Peng, Yuting Shao, et al.
Phytomedicine (2025) Vol. 138, pp. 156411-156411
Closed Access
Tingting Yang, Yuting Peng, Yuting Shao, et al.
Phytomedicine (2025) Vol. 138, pp. 156411-156411
Closed Access
Changes in Urinary NGAL, FN, and LN Excretion in Type 2 Diabetic Patients Following Anti-Diabetic Therapy with Metformin
Anna Szeremeta, Agnieszka Jura-Półtorak, Alicja Grim, et al.
Journal of Clinical Medicine (2025) Vol. 14, Iss. 4, pp. 1088-1088
Open Access
Anna Szeremeta, Agnieszka Jura-Półtorak, Alicja Grim, et al.
Journal of Clinical Medicine (2025) Vol. 14, Iss. 4, pp. 1088-1088
Open Access
Renal Lipid Alterations From Diabetes to Early‐Stage Diabetic Kidney Disease and Mitophagy: Focus on Cardiolipin
Zhijie Li, Hongmiao Wang, Nan Liu, et al.
Journal of Cellular and Molecular Medicine (2025) Vol. 29, Iss. 3
Open Access
Zhijie Li, Hongmiao Wang, Nan Liu, et al.
Journal of Cellular and Molecular Medicine (2025) Vol. 29, Iss. 3
Open Access
Iron‐Deficiency Anemia Elevates Risk of Diabetic Kidney Disease in Type 2 Diabetes Mellitus
Bin Huang, Wenjie Wen, Shandong Ye
Journal of Diabetes (2025) Vol. 17, Iss. 2
Open Access
Bin Huang, Wenjie Wen, Shandong Ye
Journal of Diabetes (2025) Vol. 17, Iss. 2
Open Access
Urinary DcR2/Cr level predicts renal outcomes in patients with diabetic kidney disease
Jia Chen, Weidong Wang, Fang Yu, et al.
Journal of Clinical & Translational Endocrinology (2025) Vol. 40, pp. 100387-100387
Open Access
Jia Chen, Weidong Wang, Fang Yu, et al.
Journal of Clinical & Translational Endocrinology (2025) Vol. 40, pp. 100387-100387
Open Access
Pancreatic stone protein as a novel biomarker of microvascular complications in type II diabetes mellitus: A systematic review and meta-analysis
Nicolas Daniel Widjanarko, Nanny Natalia Mulyani Soetedjo, Maria Riastuti Iryaningrum, et al.
Tzu Chi Medical Journal (2025)
Open Access
Nicolas Daniel Widjanarko, Nanny Natalia Mulyani Soetedjo, Maria Riastuti Iryaningrum, et al.
Tzu Chi Medical Journal (2025)
Open Access
Association between neutrophil-percentage-to-albumin ratio and diabetic kidney disease in type 2 diabetes mellitus patients: a cross-sectional study from NHANES 2009–2018
Hongying Li, Yue Xu, Shuhan Fan, et al.
Frontiers in Endocrinology (2025) Vol. 16
Open Access
Hongying Li, Yue Xu, Shuhan Fan, et al.
Frontiers in Endocrinology (2025) Vol. 16
Open Access
Mechanism of LncRNA-MiRNA in Renal Intrinsic Cells of Diabetic Kidney Disease and Potential Therapeutic Direction
Xiyue Tian, Min Zhou, Jingbo Zhang, et al.
DNA and Cell Biology (2025)
Closed Access
Xiyue Tian, Min Zhou, Jingbo Zhang, et al.
DNA and Cell Biology (2025)
Closed Access
Klotho antiaging protein: molecular mechanisms and therapeutic potential in diseases
Aditya Dipakrao Hajare, Neha Dagar, Anil Bhanudas Gaikwad
Molecular Biomedicine (2025) Vol. 6, Iss. 1
Open Access
Aditya Dipakrao Hajare, Neha Dagar, Anil Bhanudas Gaikwad
Molecular Biomedicine (2025) Vol. 6, Iss. 1
Open Access
From Liver to Kidney: The Overlooked Burden of Nonalcoholic Fatty Liver Disease in Chronic Kidney Disease
R. Bogdan, Adrian Boicean, Paula Anderco, et al.
Journal of Clinical Medicine (2025) Vol. 14, Iss. 7, pp. 2486-2486
Open Access
R. Bogdan, Adrian Boicean, Paula Anderco, et al.
Journal of Clinical Medicine (2025) Vol. 14, Iss. 7, pp. 2486-2486
Open Access
Diabetic Kidney Disease: Disease Progression Driven by Positive Feedback Loops and Therapeutic Strategies Targeting Pathogenic Pathways
Gaozhi P Mo, Yao Zhu, Yue You, et al.
Diabetes Metabolic Syndrome and Obesity (2025) Vol. Volume 18, pp. 1073-1085
Open Access
Gaozhi P Mo, Yao Zhu, Yue You, et al.
Diabetes Metabolic Syndrome and Obesity (2025) Vol. Volume 18, pp. 1073-1085
Open Access
Emerging Biomarkers and Innovative Therapeutic Strategies in Diabetic Kidney Disease: A Pathway to Precision Medicine
Sahana Shetty, Renuka Suvarna, Avivar Awasthi, et al.
Diagnostics (2025) Vol. 15, Iss. 8, pp. 973-973
Open Access
Sahana Shetty, Renuka Suvarna, Avivar Awasthi, et al.
Diagnostics (2025) Vol. 15, Iss. 8, pp. 973-973
Open Access
Association between uric acid to high-density lipoprotein cholesterol ratio and chronic kidney disease in Chinese patients with type 2 diabetes mellitus: a cross-sectional study
Xiangyu Chen, Jie Zhang, Feng Lü, et al.
Frontiers in Nutrition (2025) Vol. 12
Open Access
Xiangyu Chen, Jie Zhang, Feng Lü, et al.
Frontiers in Nutrition (2025) Vol. 12
Open Access
Baseline comorbidity of cardiovascular-kidney-metabolic syndrome increases the risk of adverse clinical outcomes in patients with chronic kidney disease
Jiali Meng, Wen Li, Wenjing Fu, et al.
Frontiers in Endocrinology (2025) Vol. 16
Open Access
Jiali Meng, Wen Li, Wenjing Fu, et al.
Frontiers in Endocrinology (2025) Vol. 16
Open Access
Research progress of effective components of traditional Chinese medicine in intervening apoptosis of renal tubular epithelial cells in diabetic kidney disease
Yuxin Gong
Journal of Ethnopharmacology (2025), pp. 119874-119874
Closed Access
Yuxin Gong
Journal of Ethnopharmacology (2025), pp. 119874-119874
Closed Access
Effectiveness and safety of Tongxinluo capsule for diabetic kidney disease: A systematic review and meta-analysis
Maoying Wei, Yijia Jiang, Yi-Ting Tang, et al.
World Journal of Diabetes (2025) Vol. 16, Iss. 5
Closed Access
Maoying Wei, Yijia Jiang, Yi-Ting Tang, et al.
World Journal of Diabetes (2025) Vol. 16, Iss. 5
Closed Access
An update on renal tubular injury as related to glycolipid metabolism in diabetic kidney disease
Anqi Feng, Ruili Yin, Rong Xu, et al.
Frontiers in Pharmacology (2025) Vol. 16
Open Access
Anqi Feng, Ruili Yin, Rong Xu, et al.
Frontiers in Pharmacology (2025) Vol. 16
Open Access
Elevated Serum SERPINE2 Levels are Linked to Impaired Renal Function in Patients with Type 2 Diabetes Mellitus
Shengtian Cao, Tan Qing, Lijuan Yang
Diabetes Therapy (2025)
Open Access
Shengtian Cao, Tan Qing, Lijuan Yang
Diabetes Therapy (2025)
Open Access
2-Dodecyl-6-Methoxycyclohexa-2, 5-Diene-1, 4-Dione isolated from Averrhoa carambola L. root inhibits high glucose-induced EMT in HK-2 cells through targeting the regulation of miR-21–5p/Smad7 signaling pathway
Jingyi Li, Qiuling Pang, Xiaoman Huang, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 172, pp. 116280-116280
Open Access | Times Cited: 3
Jingyi Li, Qiuling Pang, Xiaoman Huang, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 172, pp. 116280-116280
Open Access | Times Cited: 3
Canagliflozin improves fatty acid oxidation and ferroptosis of renal tubular epithelial cells via FOXA1-CPT1A axis in diabetic kidney disease
Tian Gan, Qingzhu Wang, Yi Song, et al.
Molecular and Cellular Endocrinology (2023) Vol. 582, pp. 112139-112139
Closed Access | Times Cited: 9
Tian Gan, Qingzhu Wang, Yi Song, et al.
Molecular and Cellular Endocrinology (2023) Vol. 582, pp. 112139-112139
Closed Access | Times Cited: 9